MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY)

In the MyREMEDY study the investigators research whether the MyDiaMate self-help application is effective in strengthening the mental health of adults with type 1 diabetes in comparison with care as usual. The MyREMEDY study takes place in four countries: The Netherlands, United Kingdom, Spain, and Germany.

Inclusion Criteria: * At least 18 years old at signing the informed consent form * Type 1 diabetes diagnosis at least 6 months ago * Having access to the internet and a smartphone/tablet/laptop'/computer for the entire time of study participation * Experiencing diabetes distress (checked during a phone call between research assistant and participant. The condition is met if the participant has an average score of ≥2 on the 2-item Diabetes Distress Scale (DDS-2), representing clinically meaningful diabetes distress) Exclusion Criteria: * Having been diagnosed with a psychiatric disorder in the past 6 months for which the person is under psychological/psychiatric treatment * Suicidality * Having started a treatment with psychotropic medication in the past 3 months * Illiteracy * Experience of cognitive problems that hamper using MyDiaMate or vision/auditory problems that are hindering in daily life * Prior use of MyDiaMate (only applicable to participants in the Netherlands)